{"id":315071,"date":"2026-10-19T09:43:45","date_gmt":"2026-10-19T04:13:45","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=315071"},"modified":"2026-10-19T09:43:45","modified_gmt":"2026-10-19T04:13:45","slug":"branded-generics-life-sciences-services-and-glycol-stocks-roadmap-beacon-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-generics-life-sciences-services-and-glycol-stocks-roadmap-beacon-list\/","title":{"rendered":"3 Branded Generics, Life Sciences Services and Glycol Stocks With a Strong Future Roadmap: Alkem Laboratories, Indegene and India Glycols"},"content":{"rendered":"

Alkem Rs 5,050.00, P\/E 28.43. Indegene Rs 598.30, P\/E 35.20. India Glycols Rs 331.95, P\/E 7.58. Closing prices of 14 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Branded generics, life sciences services and glycol stocks with the clearest long-term roadmaps today include Alkem in branded generics in India along with generic exports and a presence in international markets, Indegene in commercial, medical and regulatory services for life sciences and pharma companies and India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock. FY26 revenue growth was 13.7% at Alkem, 21.6% at Indegene and 11.5% at India Glycols. P\/E stands at 28.43 for Alkem (industry 37.59), 35.20 for Indegene (industry 62.79) and 7.58 for India Glycols (industry 54.53). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Branded generics, life sciences services and glycol stocks give investors exposure to medicines, drug-industry services and renewable-based chemicals. Volumes, pricing and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three branded generics, life sciences services and glycol stocks: Alkem Laboratories for branded generics in India along with generic exports and a presence in international markets, Indegene for commercial, medical and regulatory services for life sciences and pharma companies and India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n